PARP1 and neoplasm: Generally, PARPis kill tumor cells by blocking single-strand DNA break repair and through PARP “trapping” in tumor cells that lack the ability to repair double-strand DNA damage, such as breast-related cancer antigens (BRCA) mutations and/or homologous recombination deficiency (HRD) (Kotsopoulos et al., 2016).